Dry eye disease affects up to 15% of the U.S. population and is one of the largest markets in the ophthalmology field.

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

Patients with T2d with more severe peripheral neuropathy have a 4-fold DED risk compared with patients with mild or no peripheral neuropathy.

Aldeyra Therapeutics (ALDX) announced the resubmission of a New Drug Application to the FDA for topical ocular reproxalap, an ...

Aldeyra Therapeutics has once again filed for Food and Drug Administration of its proposed reproxalap drug candidate for the treatment of signs and symptoms of dry-eye disease.

Remember to blink. Thinking about blinking may feel silly, Dr. Moy said, but it’s a great way to prevent your eyes from ...

More than a year after Adelsten’s first symptoms appeared, Johns Hopkins doctors ultimately diagnosed her with Sjogren’s syndrome, an autoimmune disease often associated with dry eye and dry mouth.

Patients with Sjögren disease had more damage to their oil-producing Meibomian glands than people with other varieties of dry ...

DED pain origins are important to consider when determining treatment strategies for individuals with the disorder.

“Studies show that if you read for 30 minutes silently and you have dry eye disease, you’ll read 28 words-per-minute slower," ...

The results of the study show that treatment with Carragelose eye drops for four weeks significantly improves dry eye-related symptoms by 54%. Next to excellent tolerability, patients also reported a ...